ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

CEO

Pekerja

Negara

Amerika Syarikat

ISIN

US04522R1014

WKN

000A3D7BB

Penyenaraian

7A9.MU

0 Comments

Kongsi pendapat anda

FAQ

Apakah simbol saham ASLAN Pharmaceuticals?▼

Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa Boerse Muenchen, saham ASLAN Pharmaceuticals didagangkan di bawah simbol 7A9.MU.

Berapa ramai pekerja yang dimiliki oleh ASLAN Pharmaceuticals?▼

Sehingga September 05, 2026, syarikat mempunyai 35 pekerja.

ASLAN Pharmaceuticals terletak dalam sektor apa?▼

ASLAN Pharmaceuticals beroperasi dalam sektor Teknologi.

Bilakah ASLAN Pharmaceuticals menyiapkan split saham?▼

ASLAN Pharmaceuticals tidak mempunyai sebarang split baru-baru ini.

Di manakah ibu pejabat ASLAN Pharmaceuticals?▼

Ibu pejabat ASLAN Pharmaceuticals terletak di 190 Elgin Avenue, Amerika Syarikat.